Investigating monocyte dysfunction in Down Syndrome

研究唐氏综合症的单核细胞功能障碍

基本信息

项目摘要

PROJECT SUMMARY We are requesting an Administrative Supplement for the INCLUDE Project for R01 AR076242 “IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis”. The proposed studies for the in this Supplement are within the scope of the active parent grant, focused on Down syndrome (DS) and are aligned with the goals of the overall INCLUDE Project—Component 1: Targeted high risk – high reward basic science studies highly relevant to DS. Our studies take advantage of a growing registry and biorepository of DS individuals that has been established at the Benaroya Research Institute by Drs. Bernard Khor and Jane Buckner. The objectives of this administrative supplement are to better understand innate immune alterations in DS. Individuals with DS have immune dysfunction evidenced by decreased vaccine responses, increased severity of viral infections and increased incidence of certain autoimmune diseases, including autoimmune thyroiditis, type 1 diabetes and juvenile idiopathic arthritis (JIA). DS individuals also have increased type 1 IFN responses and increased amounts of some inflammatory cytokines and specific alterations in T and B cells. However, how these alterations lead to the overall changes in immunity in DS is not well-understood. Importantly, there has been much focus on adaptive immune responses in DS, with less focus on cells of the innate immune system, including monocytes and macrophages, important in the pathogenesis of many autoimmune diseases, including (JIA). This supplement is within the scope of the Parent R01 as it: 1) investigates monocytes and TLR responses in these cells, which are the focus of the parent R01, 2) relates to a form of juvenile arthritis seen more frequently in individuals with DS, as the parent grant focuses on another form of juvenile arthritis (systemic juvenile idiopathic arthritis (SJIA)), and 3) will leverage our existing single cell RNA-Seq (scRNA-Seq) data funded by the parent R01. Data generated from this supplement will inform our parent R01 by giving us additional monocyte scRNA-Seq datasets to compare with our already generated scRNA-Seq datasets from children with SJIA-associated MAS and matched controls. This supplement is within NIAMS INCLUDE Program priorities to better understand arthritic disorders in DS across the lifepan. Because monocytes and macrophages are key players in pathogenesis of all forms of arthritis, understanding whether these cells and their responses are dysregulated in DS will lead to a better understanding of their contributions to the increased incidence of arthritis in children with DS.
项目总结

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Detection of neutrophil extracellular traps in patient plasma: method development and validation in systemic lupus erythematosus and healthy donors that carry IRF5 genetic risk.
  • DOI:
    10.3389/fimmu.2022.951254
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Matta, Bharati;Battaglia, Jenna;Barnes, Betsy J.
  • 通讯作者:
    Barnes, Betsy J.
Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Betsy J Barnes其他文献

Betsy J Barnes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Betsy J Barnes', 18)}}的其他基金

Implications for Speckled proteins 110 and 140 in adaptive immunity
斑点蛋白 110 和 140 对适应性免疫的影响
  • 批准号:
    10726020
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimer’s disease
IRF5 在阿尔茨海默病中调节 tau 蛋白积累的新作用
  • 批准号:
    10302599
  • 财政年份:
    2021
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10199939
  • 财政年份:
    2019
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10454915
  • 财政年份:
    2019
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    9982787
  • 财政年份:
    2019
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10663266
  • 财政年份:
    2019
  • 资助金额:
    $ 38.37万
  • 项目类别:
Determining the function of IRF5 tumor suppressor in HCV pathogenesis
确定 IRF5 抑癌基因在 HCV 发病机制中的功能
  • 批准号:
    9108325
  • 财政年份:
    2015
  • 资助金额:
    $ 38.37万
  • 项目类别:
Determining the function of IRF5 tumor suppressor in HCV pathogenesis
确定 IRF5 抑癌基因在 HCV 发病机制中的功能
  • 批准号:
    9147052
  • 财政年份:
    2015
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an
IRF5-TNPO3 基因座:将 TNPO3 作为 IRF5 表达的独特调节因子纳入其中
  • 批准号:
    8664081
  • 财政年份:
    2014
  • 资助金额:
    $ 38.37万
  • 项目类别:
IRF5-TNPO3 locus: Inclusion of TNPO3 as a unique regulator of IRF5 expression an
IRF5-TNPO3 基因座:将 TNPO3 作为 IRF5 表达的独特调节因子纳入其中
  • 批准号:
    9220283
  • 财政年份:
    2014
  • 资助金额:
    $ 38.37万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 38.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了